Iliac nodal metastases from carcinoma of the penis treated surgically

BJU International

Volumn 86, Issue 6, 2000, Pages 690-693

  Lopes, A ^a,b   Bezerra, A L R ^a   Serrano, S V ^a   Hidalgo, G S ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b Antonio Prudente   (Brazil)

Author keywords

Carcinoma; Ilio inguinal lymphadenectomy; Penis; Prognosis; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FOLLOW UP; HUMAN; ILIAC ARTERY; INGUINAL LYMPH NODE; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; PENIS AMPUTATION; PENIS CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; HUMAN; ILIUM; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGE; PENILE NEOPLASMS; PROGNOSIS;

EID: 0033780710     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00862.x     Document Type: Article

References (19)

1. Brumini R. Resultados. In Câncer No Brasil: Dados Histopatológicos. Campanha Nacional de Combate Ao Câncer. Rio de Janeiro: Ministério Da Saúde, 1982: 1-105
2. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39: 456-66
3. Catalona WJ. Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: technique and preliminary results. J Urol 1988; 140: 306-10
4. Lopes A, Rossi BM, Fonseca FP, Morini S. Unreliability of modified inguinal lymphadenectomy for clinical staging of penile carcinoma. Cancer 1996; 77: 2099-102
5. Pow-Sang JE, Benavente V, Pow-Sang JM, Pow-Sang M. Bilateral ilioinguinal lymph node dissection in the management of cancer of the penis. Sem Surg Oncol 1990; 6: 241-2
6. Srinivas V, Morse MJ, Herr HW, Sogani PC, Whitmore WF Jr. Penile cancer: relation of extent of nodal metastasis to survival. J Urol 1987; 137: 880-2
7. Lopes A, Hidalgo GS, Kowalski LP, Torloni H, Rossi BM, Fonseca FP. Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol 1996; 156: 1637-42
8. Harmer MH. Penis (ICD-0187). In TNM Classification of Malignant Tumors. 3rd edn. Geneva: International Union Against Cancer, 1978: 126-8
9. DeKernion JB, Tynberg P, Persky L, Fegen JP. Carcinoma of the penis. Cancer 1973; 32: 1256-62
10. Gursel EO, Geurgountzosz C, Uson AC, Melicow MM, Veenema RS. Penile cancer: clinicopathologic study of 64 cases. Urology 1973; 1: 569-478
11. Ravi R. Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol 1993; 72: 817-9
12. Puras A, Gonzalez-Flores B, Rodriguez R. Treatment of carcinoma of the penis. Proc Kimbrough Urol Semin 1978; 12: 143-52
13. Horenblas S, Van Tinteren H, Delemarre JFM, Moonen LMF, Lustig V, Van Waardenburg EW. Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J Urol 1993; 149: 492-7
14. Corral DA, Sella A, Pettaway CA, Amato RJ, Jones DM, Ellerhorst J. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin. J Urol 1998; 160: 1770-4
15. Haas GP, Blumenstein BA, Gagliano RG et al. Cisplatin, Methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol 1999; 161: 1823-5
16. Pizzocaro G, Piva L, Bandieramonte G, Tana S. Up-to-date management of carcinoma of the penis. Eur Urol 1997; 32: 5-15
17. Pizzocaro G, Piva L. Adjuvant and neoadjuvant vincristine, bleomycin and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol 1988; 27: 823-4
18. Skinner DG, Leadbetter WF, Kelley SB. The surgical management of squamous cell carcinoma of the penis. J Urol 1972; 107: 273-8
19. Kamat MR, Kulkarni JN, Tongaonkar HB. Carcinoma of the penis: the Indian experience. J Surg Oncol 1993; 52: 50-5